Sanofi Clinches Key Phase III Immunology Win With Rilzabrutinib

Prior Late-Stage Readout In Pemphigus Was A Setback

 
• By Mandy Jackson
  
Winner as style of life. Horizontal shot of young beautiful woman in sports clothing keeping arms raised and smiling while passing finish line during jogging.
Sanofi may have the first BTK inhibitor approved for ITP • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D